Fabritz, Larissa
Guasch, Eduard
Antoniades, Charalambos
Bardinet, Isabel
Benninger, Gerlinde
Betts, Tim R.
Brand, Eva
Breithardt, Günter
Bucklar-Suchankova, Gabriela
Camm, A. John
Cartlidge, David
Casadei, Barbara
Chua, Winnie W. L.
Crijns, Harry J. G. M.
Deeks, Jon
Hatem, Stéphane
Hidden-Lucet, Françoise
Kääb, Stefan
Maniadakis, Nikos
Martin, Stephan
Mont, Lluis
Reinecke, Holger
Sinner, Moritz F.
Schotten, Ulrich
Southwood, Taunton
Stoll, Monika
Vardas, Panos
Wakili, Reza
West, Andy
Ziegler, André
Kirchhof, Paulus
Article History
First Online: 24 December 2015
Competing interests
: L.F. declares that she has received institutional research grants from the British Heart Foundation (BHF), Cardiovascular Therapeutics, the European Union (EU), the German Research Foundation (DFG), Gilead, and the University of Birmingham. G. Benninger has received research grants from Biosense, Bristol-Myers Squibb (BMS), Daiichi Sankyo, Pfizer, Sanofi Aventis, and St. Jude Medical. T.R.B. declares that he has received consulting fees and honoraria from Boehringer Ingelheim, Boston Scientific, Medtronic, and St. Jude Medical, and that he has received research grants from BMS and St. Jude Medical. E.B. has received consulting fees/honoraria from Daiichi Sankyo, Genzyme, and Shire, and has received research grants (to institution) from Amgen, AstraZeneca, Boehringer Ingelheim, the DFG, Heisenberg professorship, the Else Kröner-Fresenius-Foundation, the EU, Genzyme, the German Ministry of Education and Research (BMBF), the Kuratorium für Dialyse und Nierentransplantation (KfH)-Stiftung Präventivmedizin, Novartis, Sanofi Aventis, Shire, and the Société Française d'Hypertension Artérielle. G. Breithardt declares that he has received consulting fees/honoraria from Bayer Healthcare, BMS, MSD, Pfizer, and Portola, and that he has received research grants (to institution) from Biosense, BMS/Pfizer, Daiichi Sankyo, Sanofi Aventis, and St. Jude Medical. G.B.-S. is an employee of Roche Professional Diagnostics. A.J.C. declares that he has received consulting fees/honoraria from Actelion, AstraZeneca, Bayer Healthcare, Boehringer Ingelheim, BMS, Boston Scientific, ChanRx, Daiichi Sankyo, Gilead, GlaxoSmithKline, Incarda, Infobionic, Johnson & Johnson, Laguna, Medtronic, Menarini, Merck, Milestone, Mitsubishi, MSD, Novartis, Otsuka Pharma, Pfizer, Richmond Pharmacology, Sanofi, Servier, Sorin, St. Jude Medical, Takeda, and Xention, and that he is a member of the speaker's bureau for Pfizer. B.C. has received research grants from charities, the EU, and the Medical Research Council. H.J.G.M.C. declares that he has received consulting fees/honoraria from Bayer, Boehringer Ingelheim, BMS, and Pfizer. J.D. has received research grants from the University of Birmingham. S.H. declares that he has received consulting fees/honoraria from Sanofi and Servier, and that he has received research grants from the EU (H2020, FP7) and Fondation Leducq. F.H.-L. declares that she has received consulting fees from Biotronik and Medtronic, and honoraria from MEDA. S.K. declares that he has received research grants from the BMBF and the German Centre for Cardiovascular Research (DZHK). N.M. declares that he has received consulting fees/honoraria from AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Menarini, Novartis, Pfizer, Roche, Sanofi, and Servier, and that he has received research grants (to institution) from the aforementioned manufacturers. L.M. declares that he has received consulting fees/honoraria from Biosense, Biotronik, Boston Scientific, Medtronic, Sorin, and St. Jude Medical, and that he has received research grants from Biotronik, Boston Scientific, Medtronic, and St. Jude Medical. H.R. declares that he has participated in the multicentre trials BARD Longlesions, BARD BelowTheKnee, BIOTRONIK BioFlex, EUROCOR Freeway, and PLURISTEM. U.S. declares that he has received consulting fees/honoraria from AOP Orphan Pharmaceuticals, Bayer, Correvio, Johnson and Johnson, and Roche Diagnostics, and that he has received research grants from the Center of Translational and Molecular Medicine (Ministry for Economic Affairs of NL), the Dutch Heart Foundation, the EU, the Fondation Leducq, Medtronic, Netherlands Genomics Initiative, and Roche. M.S. declares that she has received research grants from the BMBF, the DFG, and the EU. P.V. declares that he has received consulting fees/honoraria from Bayer, Boehringer Ingelheim, Menarini, and Servier. R.W. declares that he has received research grants from the BMBF and the DZHK, and consulting fees/honoraria from Biotronik, Boehringer Ingelheim, Boston Scientific, and BMS/Pfizer. A.Z. is an employee of Roche Professional Diagnostics. P.K. declares that he has received consulting fees/honoraria from 3M Medica, AstraZeneca, Bayer Healthcare, Biosense Webster, BMS, Boehringer Ingelheim, Daiichi Sankyo, the German Cardiac Society-Akademie, Johnson & Johnson, MEDA Pharma, Medtronic, Merck, MSD, Otsuka Pharma, Pfizer, Sanofi, Servier, Siemens, and Takeda, and that he has received research grants from the BHF, the BMBF, BMS/Pfizer, Cardiovascular Therapeutics, Daiichi Sankyo, the DFG, the EU, the Fondation Leducq, Medtronic, OMRON, Sanofi, and St. Jude Medical. E.G., C.A., I.B., D.C., W.W.L.C., S.M., M.F.S., T.S., and A.W. declare no competing interests.